http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11456081-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35855184e8b812a058f885cfd2dcf57f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40
filingDate 2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c05ed09e5c88fd901e5a627ab49ffaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c65566998696294673d9d8b70451ccd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bce3ad98d5acb44b4e7051b4fca9184
publicationDate 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11456081-B1
titleOfInvention Sensitive drug distribution systems and methods
abstract A drug distribution system and method utilizes a central pharmacy and database to track all prescriptions for a sensitive drug. Information is kept in the database regarding all physicians allowed to prescribe the sensitive drug, and all patients receiving the drug. Abuses are identified by monitoring data in the database for prescription patterns by physicians and prescriptions obtained by patients and/or caregivers. Further verification is made that the physician is eligible to prescribe the drug by consulting a separate database, and optionally whether any actions are taken against the physician. Multiple controls beyond those for normal drugs are imposed on the distribution depending on the sensitivity of the drug.
priorityDate 2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6045501-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7668730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5737539-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7765106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011145018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7895059-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002032581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012209623-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001001144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4847764-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7765107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6021392-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012065999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006062734-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015202588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6564121-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005090425-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5845255-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003046110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004117126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003160698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8589182-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017326033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4976351-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011119085-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014207480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6755784-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4847764-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8731963-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010138237-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003127508-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801852-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7519540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014207481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8457988-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002111833-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005222874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7797171-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016357924-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004162740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002177232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005177398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6315720-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005216309-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014188504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002042725-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014074283-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014329213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003050802-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004019567-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6561977-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457754985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876

Total number of triples: 81.